Catalog No | Chemical Name | CAS Number | Purity | Chemical Structure |
---|---|---|---|---|
122520 | BD-1047 dihydrobromide | 138356-21-5 | 98% | ![]() |
BD-1047 dihydrobromide is a selective functional antagonist of sigma receptors, shows | ||||
122517 | BIX 01294 Trihydrochloride | 1392399-03-9 | 98% | ![]() |
BIX01294 is a potent chemical inhibitor of G9a methyltransferase that catalyzes the m | ||||
122514 | Bleomycin sulfate | 9041-93-4 | 98% | ![]() |
Bleomycin is a glycopeptide antibiotic; used as an anticancer agent; Bleomycin acts b | ||||
122507 | Bicalutamide | 90357-06-5 | 98% | ![]() |
Bicalutamide is an oral non-steroidal anti-androgen for prostate cancer; binds to the | ||||
122205 | BIX02188 | 334949-59-6 | 98% | ![]() |
BIX02188 is a selective inhibitor of MEK5 with IC50 of 4.3 nM, also inhibits ERK5 cat | ||||
121807 | Bilastine | 202189-78-4 | 98% | ![]() |
Bilastine is a selective histamine H1 receptor antagonist used for treatment of aller | ||||
121417 | BMS-777607 | 1025720-94-8 | 98% | ![]() |
BMS-777607 is an inhibitor of MET tyrosine kinase with potential antineoplastic activ | ||||
121411 | Benzyl Dichlorophosphite | 76101-29-6 | 98% | ![]() |
Coming soon! | ||||
121403 | BPTES | 314045-39-1 | 98% | ![]() |
BPTES is a potent and selective allosteric inhibitor of kidney-type glutaminase (GLS) | ||||
121401 | Belotecan hydrochloride | 213819-48-8 | 98% | ![]() |
Belotecan Hydrochloride is the hydrochloride salt of the semi-synthetic camptothecin | ||||
120702 | Belinostat acid | 866323-87-7 | 98% | ![]() |
Coming soon! | ||||
120405 | Benazepril | 86541-75-5 | 98% | ![]() |
Coming soon! | ||||
120108 | BX471 | 217645-70-0 | 98% | ![]() |
BX471 is a potent, selective non-peptide CCR1 antagonist (Ki = 1 nM for human CCR1); | ||||
120107 | BMH-21 | 896705-16-1 | 98% | ![]() |
BMH-21 is a small molecule DNA intercalator that binds ribosomal DNA and inhibits RNA | ||||
111912 | BIX 02189 | 1265916-41-3 | 98% | ![]() |
BIX 02189 is a selective MEK5/ERK5 inhibitor with an IC50 of 59 nM, which was reporte | ||||
111907 | BAZ2-ICR | 1665195-94-7 | 98% | ![]() |
BAZ2-ICR is a small molecule inhibitor of BAZ2A (Kd = 109 nM; IC50 = 130 nM) and BAZ2 | ||||
111903 | BMS-863233 HCl | 1169562-71-3 | 98% | ![]() |
BMS-863233, also known as XL-413, is an orally bioavailable cell division cycle 7 hom | ||||
111902 | BAY 57-1293 | 348086-71-5 | 98% | ![]() |
BAY 57-1293 is a potent helicase primase inhibitor. BAY 57-1293 inhibits replication | ||||
111001 | BIX02188 | 1094614-84-2 | 98% | ![]() |
BIX02188 is a MEK5-selective inhibitor with an IC50 of 0.8 1.0 M, which inhibited ca | ||||
110908 | BMS-754807 | 1001350-96-4 | 98% | ![]() |
BMS-754807 is a potent and reversible inhibitor of IGF-1R/InsR with IC50 of 1.8 nM/1. | ||||
110227 | BRD4770 | 1374601-40-7 | 98% | ![]() |
BRD4770 is a novel G9a(EHMT2) inhibitor with EC50 of 5 uM (trimethylated H3K9 in PANC | ||||
110204 | 5-Bromo-2-iodopyridine | 223463-13-6 | 98% | ![]() |
Coming soon! | ||||
102612 | Blonanserin | 132810-10-7 | 98% | ![]() |
Blonanserin is a D2/5-HT2 receptor antagonist, atypical antipsychotic. | ||||
102601 | BRD73954 | 1440209-96-0 | 98% | ![]() |
BRD73954 ia a potent and selective HDAC inhibitor with IC50 of 36 nM and 120 nM for H | ||||
101916 | BIO-32546 | 1548743-66-3 | 98% | ![]() |
Coming soon! | ||||
101401 | BIO-acetoxime | 667463-85-6 | 98% | ![]() |
BIO-Acetoxime is a potent and selective GSK-3a/b inhibitor that reduces invasiveness | ||||
101203 | BIX01294 | 935693-62-2 | 98% | ![]() |
BIX01294 is an inhibitor of G9a histone methyltransferase with IC50 of 2.7 M. | ||||
92303 | Bardoxolone methyl | 218600-53-4 | 98% | ![]() |
Bardoxolone methyl (also known as “RTA 402” and “CDDO-methyl ester”) is an or | ||||
92207 | BMS-626529 | 701213-36-7 | 98% | ![]() |
BMS-626529 is a potent HIV-1 attachment inhibitor, which is also the phosphonooxymeth | ||||
92202 | 2-Bromo-3-Fluoro-6-Picoline | 374633-36-0 | 98% | ![]() |
Coming soon! |
Overnight Delivery
Fast & Safe Delivery Worldwide
Safety and Security
Intimate Service
Copyright 2015-2022 武汉永璨生物科技有限公司 版权所有 | 鄂ICP备17005301号-1